Dyslipidemia
Conditions
Interventions
Group 1:jieyuqutanhuazhuo prescription
Group 2:Xuezhikang capsule
Sponsors
Guang'anmen Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meet the Western medical diagnostic criteria for dyslipidemia:TC=6.22mmol/L or TG=2.26mmol/L or LDL-C=4.14mmol/L or HDL-C<1.04mmol/L; 2. Patients aged 18-80 years; 3. Fulfill diagnostic criteria for the TCM syndrome of qi depression and phlegm obstruction. 4. Voluntarily joined this study and has signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Have suffered from acute myocardial infarction, cerebrovascular accident, severe trauma, etc. within half a year; 2. Secondary dyslipidemia caused by diseases such as hypothyroidism, nephrotic syndrome, diabetes, etc. 3. Patients who need long-term use of lipid-lowering agents after PCI or other major surgery. 4. Drugs that affect blood lipid metabolism or thyroid treatment drugs such as glucocorticoids, thyroid hormones, thiazide diuretics, and beta blockers are being used. 5. Patients with systemic serious diseases such as heart, liver, kidney, hematopoietic system, and immune system. 6. Pregnant, lactating women or who plan to become pregnant during the trial or who plan to become pregnant. 7. Allergic constitution, patients who may be allergic to this drug or psychotic patient. 8. Any other situation that the investigators consider will affect the efficacy and safety of the investigational drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Symptom Scale;TC;TG;LDL-C;HDL-C; | — |
Countries
China
Contacts
Public ContactYao Kuiwu
Guang'anmen Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed